Cell culture methods for producing recombinant proteins in the presence of reduced levels of one or more contaminants
View Patent ↗The invention relates to cell culture methods, kits and cell lines for producing recombinant products, e.g. therapeutic proteins and antibodies, in the presence of reduced levels of one or more contaminants and further to methods of purifying those products.
1. A method of enriching for a recombinant protein in cell culture, the method comprising:
a) transfecting into a host cell, a first nucleic acid molecule comprising a nucleotide sequence encoding a recombinant protein and a second nucleic acid molecule comprising a nucleotide sequence encoding at least one anti-apoptotic protein selected from a protein comprising the amino acid sequence set forth in SEQ ID NO:6, 8 or 10 or a functional fragment thereof having anti-apoptotic activity, wherein both nucleotide sequences are operably linked to a DNA element comprising a nucleotide sequence set forth in SEQ ID NO:1, wherein the DNA element is capable of opening chromatin and/or maintaining the chromatin in an open state; and
b) culturing the host cell under conditions such that the recombinant protein is produced in the presence of reduced levels of one or more contaminants selected from host cell protein and DNA, thereby to enrich for the recombinant protein in cell culture.
2. The method of claim 1 , further comprising the step of harvesting the recombinant protein from the cell culture.
3. The method of claim 2 , wherein the levels of one or more contaminants selected from host cell protein and DNA are reduced during the harvesting step.
4. The method of claim 1 , wherein both the first nucleic molecule and the second nucleic acid molecule are cloned into a single vector.
5. The method of claim 1 , wherein the first nucleic acid molecule and the second nucleic acid molecule are cloned into separate vectors.
6. The method of claim 4 or 5 , wherein the vector is a plasmid.
7. The method of claim 4 or 5 , wherein the vector is a viral vector.
8. The method of claim 1 , wherein the second nucleic acid molecule is introduced before the first nucleic acid molecule.
9. The method of claim 1 , wherein the first and the second nucleic acid molecules are introduced simultaneously.
10. The method of claim 1 , wherein the first nucleic acid molecule comprises two nucleotide sequences, each encoding a recombinant protein.
11. The method of claim 1 , wherein the first nucleic acid molecule further comprises one or more nucleotide sequences chosen from: (a) a nucleotide sequence capable of enhancing translation; (b) a nucleotide sequence capable of increasing secretion; and (c) a nucleotide sequence capable of increasing the mRNA stability, wherein the one or more nucleotide sequences set forth in (a)-(c) are operably linked to the nucleotide sequence encoding the recombinant protein.
12. The method of claim 1 , wherein the host cell is a mammalian cell.
13. The method of claim 12 , wherein the mammalian cell is chosen from a BHK21 cell, a CHO cell, a CHO-K1 cell, a CHO-DUXX cell, an NSO cell or an Sp2/0 cell.
14. The method of claim 12 , wherein the mammalian cell is a Chinese Hamster Ovary Cell (CHO cell).
15. The method of claim 1 , wherein the recombinant protein is a therapeutic protein.
16. The method of claim 1 , wherein the recombinant protein is an antibody or an antigen-binding fragment thereof.
17. The method of claim 16 , wherein the antibody is a monoclonal antibody.
18. The method of claim 1 , wherein the host cell is cultured in serum free medium.
19. The method of claim 18 , wherein the medium is free of animal products.
20. The method of claim 18 , wherein the medium is a protein free media.
21. The method of claim 1 , wherein the transfecting step comprises: (a) placing the host cell in an electroporation device comprising a barrier having an opening suitable for receiving the cell; (b) securing the host cell in the opening; (c) contacting the host cell with an electric current such that the current passes through the host cell; (d) monitoring the ratio between the current and voltage in the electroporation device; and (e) adjusting the magnitude of the voltage to optimize electroporation.
22. The method of claim 21 , wherein the barrier comprises a dielectric material.
23. The method of claim 1 , wherein transfection comprises electroporation.
24. A method of harvesting a recombinant protein expressed according to the method of claim 1 , wherein the harvesting step does not comprise the use of protein A and comprises one or more steps chosen from precipitation of the recombinant protein from a supernatant; crystallization; high performance tangential flow filtration (HPTFF), flow through chromatography; adsorption chromatography.
25. The method of claim 24 , wherein the adsorption chromatography step is an ion exchange step.
26. The method of claim 24 , wherein the harvesting step includes at least one centrifugation step.
27. The method of claim 24 , wherein the levels of one or more contaminants are reduced.
28. The method of claim 27 , wherein the levels of one or more contaminants selected from host cell protein and DNA are reduced by about 20%, or about 30%, or about 40%, or about 50%, or about 60%, or about 70%, or about 80%, or about 90%, or about 95%, or about 96%, or about 97%, or about 98%, or about 99%, or more, when the recombinant protein is co-expressed with the anti-apoptotic protein or functional fragment thereof having anti-apoptotic activity relative to the levels of the one or more contaminants produced when the recombinant protein is expressed alone.
29. A method of enriching for a recombinant protein in cell culture, the method comprising:
a) transfecting into a host cell, a first nucleic acid molecule comprising a nucleotide sequence encoding a recombinant protein and a second nucleic acid molecule comprising a nucleotide sequence encoding at least one anti-apoptotic protein selected from a protein comprising the amino acid sequence set forth in SEQ ID NO:6, 8 or 10 or a functional fragment thereof having anti-apoptotic activity, wherein both nucleotide sequences are operably linked to a DNA element consisting of a nucleotide sequence set forth in SEQ ID NO:1, wherein the DNA element is capable of opening chromatin and/or maintaining the chromatin in an open state; and
b) culturing the host cell under conditions such that the recombinant protein is produced in the presence of reduced levels of one or more contaminants selected from host cell protein and DNA, thereby to enrich for the recombinant protein in cell culture.